• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Accelerating the development of therapeutic strategy for oligometastasis.加速寡转移治疗策略的发展。
J Thorac Dis. 2019 Dec;11(12):5670-5673. doi: 10.21037/jtd.2019.12.42.
2
[Treatments for Pancreatic Cancer with Oligometastasis].[寡转移胰腺癌的治疗]
Gan To Kagaku Ryoho. 2017 Oct;44(10):827-830.
3
Can urologists introduce the concept of "oligometastasis" for metastatic bladder cancer after total cystectomy?泌尿外科医生能否介绍一下根治性膀胱切除术后转移性膀胱癌的“寡转移”概念？
Oncotarget. 2017 Dec 4;8(67):111819-111835. doi: 10.18632/oncotarget.22911. eCollection 2017 Dec 19.
4
Survival outcomes for oligometastasis in resected non-small cell lung cancer.切除的非小细胞肺癌寡转移的生存结果。
Asian Cardiovasc Thorac Ann. 2015 Oct;23(8):937-44. doi: 10.1177/0218492315596463. Epub 2015 Jul 22.
5
Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma.寡转移状态可预测转移性人乳头瘤病毒阳性口咽癌患者的生存情况。
Head Neck. 2018 Aug;40(8):1685-1690. doi: 10.1002/hed.25171. Epub 2018 May 13.
6
Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report.胰管腺癌肺寡转移灶重复切除后的长期生存：1例报告
Surg Case Rep. 2018 Mar 27;4(1):26. doi: 10.1186/s40792-018-0435-2.
7
Detection and management of oligometastatic disease in oesophageal cancer and identification of prognostic factors: A systematic review.食管癌寡转移疾病的检测与管理及预后因素的识别：一项系统评价
World J Gastrointest Oncol. 2019 Sep 15;11(9):741-749. doi: 10.4251/wjgo.v11.i9.741.
8
Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis.非小细胞肺癌肺寡转移的外科治疗
World J Surg Oncol. 2017 Feb 2;15(1):36. doi: 10.1186/s12957-017-1105-8.
9
Radiation therapy for oligorecurrence in prostate cancer. Preliminary results of our centre.
Actas Urol Esp. 2017 Dec;41(10):646-651. doi: 10.1016/j.acuro.2017.06.001. Epub 2017 Jul 21.
10
[Not Available].
Bull Cancer. 2016 Jun;103(6 Suppl 1):S48-54. doi: 10.1016/S0007-4551(16)30145-X.

引用本文的文献

1
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.利用靶病灶异质性评估晚期肺癌的治疗效果。
PLoS One. 2021 Jul 1;16(7):e0252041. doi: 10.1371/journal.pone.0252041. eCollection 2021.

本文引用的文献

1
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.同步寡转移非小细胞肺癌的定义：共识报告。
J Thorac Oncol. 2019 Dec;14(12):2109-2119. doi: 10.1016/j.jtho.2019.07.025. Epub 2019 Aug 6.
2
Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.定义同步寡转移非小细胞肺癌：系统评价。
J Thorac Oncol. 2019 Dec;14(12):2053-2061. doi: 10.1016/j.jtho.2019.05.037. Epub 2019 Jun 11.
3
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.寡转移非小细胞肺癌患者的局部巩固治疗与维持治疗或观察：多机构、Ⅱ期、随机研究的长期结果。
J Clin Oncol. 2019 Jun 20;37(18):1558-1565. doi: 10.1200/JCO.19.00201. Epub 2019 May 8.
4
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.寡转移癌症患者立体定向消融放疗与标准姑息治疗的比较（SABR-COMET）：一项随机、2 期、开放标签试验。
Lancet. 2019 May 18;393(10185):2051-2058. doi: 10.1016/S0140-6736(18)32487-5. Epub 2019 Apr 11.
5
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌：欧洲肿瘤内科学会临床实践诊断、治疗及随访指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.
6
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.NCCN 指南解读：非小细胞肺癌，第 5 版，2018 年。
J Natl Compr Canc Netw. 2018 Jul;16(7):807-821. doi: 10.6004/jnccn.2018.0062.
7
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.寡转移前列腺癌复发的监测或转移灶导向治疗：一项前瞻性、随机、多中心 II 期试验。
J Clin Oncol. 2018 Feb 10;36(5):446-453. doi: 10.1200/JCO.2017.75.4853. Epub 2017 Dec 14.
8
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.局限性转移性非小细胞肺癌的巩固性放疗：一项 2 期随机临床试验。
JAMA Oncol. 2018 Jan 11;4(1):e173501. doi: 10.1001/jamaoncol.2017.3501.
9
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.不可切除结直肠癌肝转移的局部治疗：一项随机II期试验的结果
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx015.
10
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.一线全身治疗后无进展的寡转移性非小细胞肺癌患者的局部巩固治疗与维持治疗或观察比较：一项多中心、随机、对照、2期研究
Lancet Oncol. 2016 Dec;17(12):1672-1682. doi: 10.1016/S1470-2045(16)30532-0. Epub 2016 Oct 24.

Accelerating the development of therapeutic strategy for oligometastasis.

作者信息

Shimada Yoshihisa

机构信息

Department of Thoracic Surgery, Tokyo Medical University, Japan, Tokyo.

出版信息

J Thorac Dis. 2019 Dec;11(12):5670-5673. doi: 10.21037/jtd.2019.12.42.

DOI:10.21037/jtd.2019.12.42
PMID:32030297
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6987990/
Abstract
摘要